Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ceribell (CBLL) Cash & Equivalents (2023 - 2025)

Ceribell (CBLL) has disclosed Cash & Equivalents for 2 consecutive years, with $23.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents changed N/A year-over-year to $23.7 million, compared with a TTM value of $23.7 million through Sep 2025, changed N/A, and an annual FY2024 reading of $194.4 million, changed N/A over the prior year.
  • Cash & Equivalents was $23.7 million for Q3 2025 at Ceribell, down from $40.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $194.4 million in Q4 2024 and bottomed at $23.7 million in Q3 2025.